John Kenneth Hautman
Founder at Treos Bio Ltd.
John Kenneth Hautman active positions
Companies | Position | Start | End |
---|---|---|---|
Treos Bio Ltd.
Treos Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Treos Bio Ltd. engages in the development of a digital cancer vaccine technology platform that provides tailored precision vaccines to patients. It focuses on cancer immunotherapies. The company was founded by john Kenneth Hautman and Julianna Lisziewicz in 2013 and is headquartered in London, the United Kingdom. | Founder | 2012-12-31 | - |
General Counsel | 2012-12-31 | - | |
Proxenia Venture Partners LLC
Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners LLC (Proxenia Venture Partners) is a venture capital firm founded in 2016 by Menghis Bairu. The firm is headquartered in wilmington, Delaware. | Corporate Officer/Principal | - | - |
Virostatics Srl
Virostatics Srl Pharmaceuticals: MajorHealth Technology Virostatics Srl is a privately held small pharmaceutical company based in Sassari, Italy. The Italian company is dedicated to discovering and developing novel compounds for the treatment of cancers and viral diseases. The company focuses on novel, selective, host cell kinase targeted inhibitors and inherently hindering the oncogene myc. The team and advisors combine scientific, business, legal, and technology expertise, spanning from translational science through preclinical and clinical drug development. Virostatics has developed a bioaerosol system to test nebulized drug treatments, inhalers, disinfectants, or devices for virucidal activity in a state-of-the-art biosafety level 3 facility. The company has developed a robust pipeline of proprietary compounds to distinguish themselves from the competition through their unique kinase selectivity, efficacy, and safety profiles. The company was founded by Franco Lori, who has been the CEO since incorporation. | Consultant / Advisor | - | - |
Corporate Officer/Principal | - | - |
Career history of John Kenneth Hautman
Former positions of John Kenneth Hautman
Companies | Position | Start | End |
---|---|---|---|
eMMUNITY, Inc.
eMMUNITY, Inc. Information Technology ServicesTechnology Services eMMUNITY, Inc. operates as a diagnostic and immunotherapy development company. It targets cancer therapy and prevention for genetically related cancer patients. The company was founded by Julianna Lisziewicz in 2013 and si headquartered in Bethesda, MD. | Director/Board Member | 2013-08-31 | 2019-08-31 |
Chief Executive Officer | 2013-08-31 | 2019-08-31 | |
Founder | 2013-08-31 | 2019-08-31 | |
Shaw Pittman Potts & Trowbridge | Private Equity Investor | - | - |
Hogan & Hartson LLP
Hogan & Hartson LLP Miscellaneous Commercial ServicesCommercial Services Hogan & Hartson LLP provides legal services. Its is specialized in areas include energy, government contracts, immigration, and litigation. The company has offices in across Asia, Europe, Latin America and North America. Hogan & Hartston was founded in 1904 and is headquartered in Washington, DC. | Corporate Officer/Principal | 1992-12-31 | 2005-12-31 |
Genetic Immunity, Inc.
Genetic Immunity, Inc. Pharmaceuticals: OtherHealth Technology Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA. | General Counsel | 2006-12-31 | - |
Corporate Secretary | 2006-12-31 | - |
Training of John Kenneth Hautman
University of Virginia | Graduate Degree |
Statistics
International
United States | 7 |
United Kingdom | 2 |
Italy | 2 |
Operational
Corporate Officer/Principal | 4 |
General Counsel | 2 |
Founder | 2 |
Sectoral
Commercial Services | 4 |
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 7 |
---|---|
Genetic Immunity, Inc.
Genetic Immunity, Inc. Pharmaceuticals: OtherHealth Technology Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA. | Health Technology |
Hogan & Hartson LLP
Hogan & Hartson LLP Miscellaneous Commercial ServicesCommercial Services Hogan & Hartson LLP provides legal services. Its is specialized in areas include energy, government contracts, immigration, and litigation. The company has offices in across Asia, Europe, Latin America and North America. Hogan & Hartston was founded in 1904 and is headquartered in Washington, DC. | Commercial Services |
Treos Bio Ltd.
Treos Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Treos Bio Ltd. engages in the development of a digital cancer vaccine technology platform that provides tailored precision vaccines to patients. It focuses on cancer immunotherapies. The company was founded by john Kenneth Hautman and Julianna Lisziewicz in 2013 and is headquartered in London, the United Kingdom. | Commercial Services |
Proxenia Venture Partners LLC
Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners LLC (Proxenia Venture Partners) is a venture capital firm founded in 2016 by Menghis Bairu. The firm is headquartered in wilmington, Delaware. | Finance |
eMMUNITY, Inc.
eMMUNITY, Inc. Information Technology ServicesTechnology Services eMMUNITY, Inc. operates as a diagnostic and immunotherapy development company. It targets cancer therapy and prevention for genetically related cancer patients. The company was founded by Julianna Lisziewicz in 2013 and si headquartered in Bethesda, MD. | Technology Services |
Virostatics Srl
Virostatics Srl Pharmaceuticals: MajorHealth Technology Virostatics Srl is a privately held small pharmaceutical company based in Sassari, Italy. The Italian company is dedicated to discovering and developing novel compounds for the treatment of cancers and viral diseases. The company focuses on novel, selective, host cell kinase targeted inhibitors and inherently hindering the oncogene myc. The team and advisors combine scientific, business, legal, and technology expertise, spanning from translational science through preclinical and clinical drug development. Virostatics has developed a bioaerosol system to test nebulized drug treatments, inhalers, disinfectants, or devices for virucidal activity in a state-of-the-art biosafety level 3 facility. The company has developed a robust pipeline of proprietary compounds to distinguish themselves from the competition through their unique kinase selectivity, efficacy, and safety profiles. The company was founded by Franco Lori, who has been the CEO since incorporation. | Health Technology |
Shaw Pittman Potts & Trowbridge | Commercial Services |
- Stock Market
- Insiders
- John Kenneth Hautman
- Experience